Details of the Drug
General Information of Drug (ID: DM1PMR3)
| Drug Name |
Sterculic acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
STERCULIC ACID; 738-87-4; Sterculinic acid; UNII-MXV06G5ROK; 9,10-methylene-9-octadecenoic acid; MXV06G5ROK; 2-octyl-1-cyclopropene-1-octanoic acid; 8-(2-octylcyclopropen-1-yl)octanoic acid; omega-(2-n-octylcycloprop-1-enyl)octanoic acid; Sterculinsaeure; ster-culic acid; Sterculia-Saeure; HSDB 3904; PubChem20404; 1-Cyclopropene-1-octanoic acid, 2-octyl-; FA(19:1)(cyclo); AC1L20NB; SCHEMBL31295; 55088-60-3; 2-Octyl-1-cyclopropene-1-octanoic acid homopolymer; CHEBI:9261; US8962837, Sterculic acid; CHEMBL3677268
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 294.5 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 5.8 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 15 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


